• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双(麦芽酚)氧钒(IV)使链脲佐菌素诱导的糖尿病大鼠体内磷酸烯醇式丙酮酸羧激酶和葡萄糖-6-磷酸酶表达正常化的机制。

Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.

作者信息

Marzban Lucy, Rahimian Roshanak, Brownsey Roger W, McNeill John H

机构信息

Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.

出版信息

Endocrinology. 2002 Dec;143(12):4636-45. doi: 10.1210/en.2002-220732.

DOI:10.1210/en.2002-220732
PMID:12446591
Abstract

Vanadium treatment normalizes plasma glucose levels in streptozotocin-diabetic rats in vivo, but the mechanism(s) involved are still unclear. Here, we tested the hypothesis that the in vivo effects of vanadium are mediated by changes in gluconeogenesis. Diabetic rats were treated with bis(maltolato)oxovanadium(IV) (BMOV) in the drinking water (0.75-1 mg/ml, 4 wk) or, for comparison, with insulin implants (4 U/d) for the final week of study. As with insulin, BMOV lowered plasma glucose and normalized phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G-6-Pase) mRNA in the liver and kidney of diabetic rats. To determine the importance of reducing hyperglycemia per se, diabetic rats were treated either with a single ED(50) dose of BMOV (0.1 mmol/kg, ip) or with phlorizin (900 mg/kg.d, 5 d). BMOV rapidly restored PEPCK and G-6-Pase mRNA and normalized plasma glucose in responsive (50%) diabetic rats but had no effect on the nonresponsive hyperglycemic rats. Phlorizin corrected plasma glucose but had no effect on PEPCK mRNA and only partially normalized G-6-Pase mRNA. In conclusion, 1) BMOV inhibits PEPCK mRNA expression and activity by rapid mechanisms that are not reproduced simply by correction of hyperglycemia; and 2) BMOV inhibits G-6-Pase expression by complex mechanisms that depend, in part, on correction of hyperglycemia.

摘要

钒治疗可使链脲佐菌素诱导的糖尿病大鼠体内血浆葡萄糖水平恢复正常,但其中涉及的机制仍不清楚。在此,我们检验了钒的体内作用是由糖异生变化介导的这一假说。给糖尿病大鼠饮用含双(麦芽醇根)氧钒(IV)(BMOV)的水(0.75 - 1 mg/ml,4周),或者作为对照,在研究的最后一周植入胰岛素(4 U/d)。与胰岛素一样,BMOV降低了糖尿病大鼠肝脏和肾脏中的血浆葡萄糖水平,并使磷酸烯醇式丙酮酸羧激酶(PEPCK)和葡萄糖-6-磷酸酶(G-6-Pase)的mRNA恢复正常。为了确定降低高血糖本身的重要性,给糖尿病大鼠单次注射ED(50)剂量的BMOV(0.1 mmol/kg,腹腔注射)或根皮苷(900 mg/kg·d,5天)。BMOV能迅速恢复反应性(50%)糖尿病大鼠的PEPCK和G-6-Pase mRNA,并使血浆葡萄糖恢复正常,但对无反应的高血糖大鼠没有影响。根皮苷纠正了血浆葡萄糖水平,但对PEPCK mRNA没有影响,仅部分使G-6-Pase mRNA恢复正常。总之,1)BMOV通过快速机制抑制PEPCK mRNA的表达和活性,而这种机制并非仅仅通过纠正高血糖就能重现;2)BMOV通过复杂机制抑制G-6-Pase的表达,这种机制部分依赖于高血糖的纠正。

相似文献

1
Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.双(麦芽酚)氧钒(IV)使链脲佐菌素诱导的糖尿病大鼠体内磷酸烯醇式丙酮酸羧激酶和葡萄糖-6-磷酸酶表达正常化的机制。
Endocrinology. 2002 Dec;143(12):4636-45. doi: 10.1210/en.2002-220732.
2
Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.急性和慢性给药后硫酸氧钒与双(麦芽醇根)氧钒(IV)降血糖特性的比较
Can J Physiol Pharmacol. 1995 Jan;73(1):55-64. doi: 10.1139/y95-008.
3
The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.双(麦芽醇)氧钒(IV)[BMOV]对链脲佐菌素诱导的糖尿病大鼠肝脏高尔基体复合物特征性生化和形态学改变的影响。
Pol J Pathol. 2002;53(4):205-13.
4
Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV).新型有机钒配合物双(麦芽酚根)氧钒(IV)的降血糖作用
Can J Physiol Pharmacol. 1993 Mar-Apr;71(3-4):263-9. doi: 10.1139/y93-041.
5
Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).长期口服双(麦芽醇)氧钒(IV)后链脲佐菌素诱导的糖尿病大鼠心脏功能障碍的改善
Can J Physiol Pharmacol. 1993 Mar-Apr;71(3-4):270-6. doi: 10.1139/y93-042.
6
Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.双(麦芽醇)氧钒(IV)长期治疗对非胰岛素依赖型糖尿病大鼠模型的影响。
Indian J Exp Biol. 2001 Sep;39(9):864-70.
7
Effects of bis(maltolato) oxovanadium (IV) on protein serine kinases in skeletal muscle of streptozotocin-diabetic rats.双(麦芽醇)氧钒(IV)对链脲佐菌素诱导的糖尿病大鼠骨骼肌中蛋白丝氨酸激酶的影响。
Mol Cell Biochem. 1999 Dec;202(1-2):131-40. doi: 10.1023/a:1007001818411.
8
Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats.双(麦芽醇)氧钒(IV)对链脲佐菌素诱导的糖尿病大鼠的作用与食物限制不同。
Am J Physiol. 1997 Jan;272(1 Pt 1):E30-5. doi: 10.1152/ajpendo.1997.272.1.E30.
9
Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.有机配体钒配合物对葡萄糖代谢的影响:糖尿病大鼠的比较研究
Br J Pharmacol. 1999 Jan;126(2):467-77. doi: 10.1038/sj.bjp.0702311.
10
A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.一种非特异性磷酸酪氨酸磷酸酶抑制剂,双(麦芽醇)氧钒(IV),可改善Zucker糖尿病脂肪大鼠的糖耐量并预防糖尿病。
Exp Biol Med (Maywood). 2005 Mar;230(3):207-16. doi: 10.1177/153537020523000307.

引用本文的文献

1
Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances.含氨基酸硫代苯胺衍生物的钒配合物:对人磷酸酶的抑制作用及在各种代谢紊乱细胞模型中的特异性
Pharmaceuticals (Basel). 2024 Feb 9;17(2):229. doi: 10.3390/ph17020229.
2
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach.氧化钒(IV)与曲酸衍生物的热力学研究:一种多技术方法。
Pharmaceuticals (Basel). 2021 Oct 12;14(10):1037. doi: 10.3390/ph14101037.
3
Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD).
高血糖诱导人肝上皮 HepG2 细胞发生关键的基因和表型改变,与非酒精性脂肪性肝病(NAFLD)的 Leprdb/J 小鼠模型相平行。
PLoS One. 2019 Dec 5;14(12):e0225604. doi: 10.1371/journal.pone.0225604. eCollection 2019.
4
Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.钒在生物作用中的作用:化学、药理学方面以及糖尿病中的代谢影响。
Biol Trace Elem Res. 2019 Mar;188(1):68-98. doi: 10.1007/s12011-018-1540-6. Epub 2018 Oct 22.
5
The Structural Basis of Action of Vanadyl (VO) Chelates in Cells.钒酰(VO)螯合物在细胞中的作用结构基础。
Coord Chem Rev. 2014 Nov 1;279:1-22. doi: 10.1016/j.ccr.2014.07.003.
6
Gene expression profile analysis of type 2 diabetic mouse liver.2 型糖尿病小鼠肝脏基因表达谱分析。
PLoS One. 2013;8(3):e57766. doi: 10.1371/journal.pone.0057766. Epub 2013 Mar 1.
7
Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor.双(蒜皮素)氧钒(IV)作为一种新型强效胰岛素模拟复合物的作用机制:对葡萄糖转运蛋白4转位和叉头框蛋白O1转录因子的调节
J Biol Inorg Chem. 2007 Nov;12(8):1275-87. doi: 10.1007/s00775-007-0295-x. Epub 2007 Sep 6.
8
Bis(quercetinato)oxovanadium IV Reverses Metabolic Changes in Streptozotocin-Induced Diabetic Mice.双(槲皮素)氧钒(IV)逆转链脲佐菌素诱导的糖尿病小鼠的代谢变化。
Rev Diabet Stud. 2007 Spring;4(1):33-43. doi: 10.1900/RDS.2007.4.33. Epub 2007 May 10.
9
Inhibition of cyclic AMP dependent protein kinase by vanadyl sulfate.硫酸氧钒对环磷酸腺苷依赖性蛋白激酶的抑制作用。
J Biol Inorg Chem. 2006 Apr;11(3):379-88. doi: 10.1007/s00775-006-0087-8. Epub 2006 Feb 28.
10
Natural vanadium-containing Mt. Fuji ground water improves hypo-activity of liver insulin receptor in Goto-Kakisaki rats.天然含钒的富士山地下水可改善五岛-垣崎大鼠肝脏胰岛素受体的低活性。
Mol Cell Biochem. 2004 Dec;267(1-2):203-7. doi: 10.1023/b:mcbi.0000049384.32179.f0.